Home

Nyxoah SA - Ordinary Shares (NYXH)

4.7100
+0.0500 (1.07%)
NASDAQ · Last Trade: Sep 18th, 3:03 PM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors
Nyxoah Files Patent Infringement Lawsuit Against Inspire Medical Systems, Inc.
Nyxoah Files Patent Infringement Lawsuit Against Inspire Medical Systems, Inc.
By Nyxoah · Via GlobeNewswire · September 15, 2025
Publication relating to transparency notifications
                
By Nyxoah · Via GlobeNewswire · September 5, 2025
Nyxoah Announces Upcoming Investor Events
Nyxoah Announces Upcoming Investor Events
By Nyxoah · Via GlobeNewswire · September 2, 2025
Information on the total number of voting rights and shares
REGULATED INFORMATION
By Nyxoah · Via GlobeNewswire · August 29, 2025
Nyxoah Reports Second Quarter Financial and Operating Results
REGULATED INFORMATION
By Nyxoah · Via GlobeNewswire · August 18, 2025
Nyxoah Announces Preliminary Results for the Second Quarter of 2025
Nyxoah Announces Preliminary Results for the Second Quarter of 2025
By Nyxoah · Via GlobeNewswire · August 11, 2025
Nyxoah Receives Approval from FDA for Genio® System for the Treatment of Obstructive Sleep Apnea
INSIDE INFORMATIONREGULATED INFORMATION
By Nyxoah · Via GlobeNewswire · August 8, 2025
Information on the total number of voting rights and shares
REGULATED INFORMATION
By Nyxoah · Via GlobeNewswire · July 29, 2025
Nyxoah to Release Second Quarter 2025 Financial Results on August 18, 2025
Nyxoah to Release Second Quarter 2025 Financial Results on August 18, 2025
By Nyxoah · Via GlobeNewswire · July 29, 2025
Nyxoah’s DREAM Pivotal Study Data Published in the Journal of Clinical Sleep Medicine
Nyxoah’s DREAM Pivotal Study Data Published in the Journal of Clinical Sleep Medicine
By Nyxoah · Via GlobeNewswire · July 28, 2025
Information on the total number of voting rights and shares
REGULATED INFORMATION
By Nyxoah · Via GlobeNewswire · June 27, 2025
Invitation to attend the extraordinary shareholders’ meeting of the Company to be held on July 2, 2025
REGULATED INFORMATIONJune 13, 2025, 7:00am CET / 1:00am ET
By Nyxoah · Via GlobeNewswire · June 13, 2025
Publication relating to transparency notifications
                
By Nyxoah · Via GlobeNewswire · May 30, 2025
Nyxoah to Present at the Jefferies Global Healthcare Conference
Nyxoah to Present at the Jefferies Global Healthcare Conference
By Nyxoah · Via GlobeNewswire · May 28, 2025
Information on the total number of voting rights and shares
By Nyxoah · Via GlobeNewswire · May 23, 2025
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Nyxoah S.A. - NYXH
NEW YORK, May 18, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of  Nyxoah S.A. (“Nyxoah” or the “Company”) (NASDAQ: NYXH).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
By Pomerantz LLP · Via GlobeNewswire · May 18, 2025
Nyxoah Reports First Quarter Financial and Operating Results
REGULATED INFORMATION
By Nyxoah · Via GlobeNewswire · May 14, 2025
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Nyxoah S.A. – NYXH
NEW YORK, May 13, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Nyxoah S.A. (“Nyxoah” or the “Company”) (NASDAQ: NYXH). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
By Pomerantz LLP · Via GlobeNewswire · May 13, 2025
Publication relating to transparency notifications
                
By Nyxoah · Via GlobeNewswire · May 9, 2025
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Nyxoah S.A. - NYXH
NEW YORK, May 09, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of  Nyxoah S.A. (“Nyxoah” or the “Company”) (NASDAQ: NYXH).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
By Pomerantz LLP · Via GlobeNewswire · May 9, 2025
Invitation to attend the annual and the extraordinary shareholders’ meetings of the Company to be held on June 11, 2025
REGULATED INFORMATIONMay 9, 2025, 7:00am CET / 1:00am ET
By Nyxoah · Via GlobeNewswire · May 9, 2025
Nyxoah to Release First Quarter 2025 Financial Results on May 14, 2025
Nyxoah to Release First Quarter 2025 Financial Results on May 14, 2025
By Nyxoah · Via GlobeNewswire · May 7, 2025
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Nyxoah S.A. - NYXH
NEW YORK, May 05, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of  Nyxoah S.A. (“Nyxoah” or the “Company”) (NASDAQ: NYXH).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
By Pomerantz LLP · Via GlobeNewswire · May 5, 2025
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Nyxoah S.A. - NYXH
NEW YORK, April 29, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of  Nyxoah S.A. (“Nyxoah” or the “Company”) (NASDAQ: NYXH). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
By Pomerantz LLP · Via GlobeNewswire · April 29, 2025
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Nyxoah S.A. - NYXH
NEW YORK, April 25, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of  Nyxoah S.A. (“Nyxoah” or the “Company”) (NASDAQ: NYXH). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
By Pomerantz LLP · Via GlobeNewswire · April 25, 2025